Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
Title
Created Date
Differential suppression of proliferation in MCF-7 and MDA-MB-231 breast cancer cells exposed to alpha-, gamma- and delta-tocotrienols is accompanied by altered expression of oxidative stress modulatory enzymes
08 November 2013
Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen
07 November 2013
Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields
31 October 2013
Somatostatin and Epidermal Growth Factor Receptors: Implications in Breast Cancer
30 October 2013
Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells
25 October 2013
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway
25 October 2013
Angiogenesis in Non-Hodgkin's Lymphoma: An Intercategory Comparison of Microvessel Density
22 October 2013
Characterization of the differential efficacy of somatostatin receptor agonists in the inhibition of the growth of experimental gliomas and identification of the intracellular mechanisms involved
17 October 2013
Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor alpha to estrogen-responsive elements
01 October 2013
Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells
01 October 2013
Display #
5
10
15
20
25
30
50
100
All
Page 170 of 172
Start
Prev
163
164
165
166
167
168
169
170
171
172
Next
End
Search
Follow us...
Latest
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study
Apoptotic effect of melatonin on ER-positive breast cancer cell lines: ADGRL4 gene expression and promoter methylation
Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells
Melatonin hybrids as multifunctional therapeutic agents: A comprehensive review
Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review
Melatonin: an essential factor for the treatment and recovery from leukemia and cancer
Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells
Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer
Melatonin as a potential inhibitory agent in head and neck cancer
Co-expression of GH and GHR isoforms in prostate cancer cell lines
Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells
Vitamin D deficiency
Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats
Molecular aspects of melatonin (MLT)-mediated therapeutic effects
Breast Cancer and Prolactin - New Mechanisms and Models
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Complete objective response to biological therapy of plurifocal breast carcinoma
How effective is chemo therapy?
Bibliography
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Vademecum
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer